Hledání v detailu akcií
Top akcie
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup		Nejlepší
prodej		Změna
(%)
ČEZ0,00
KB0,00
PKN140,06140,10,21
Msft-1,34
Nokia10,8211,1153,27
IBM-0,67
Mercedes-Benz Group AG50,1350,06-0,38
PFE-3,02
09.05.2026 2:04:00
Zpožděná data, Real-Time data info
Indexy online
WIG
Další akciové indexy

AD Index online
select
AD Index online
Výsledková sezóna
Výsledky společností
 

  • 08.05.2026
ASICS (7936.T, Tokyo)
Závěr k 8.5.2026 Změna (%) Změna (JPY) Objem obchodů (JPY)
4 640,00 0,26 12,00 -
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

Akce
Nákup / prodej ve cvičném portfoliu
Přidat do oblíbených
Nákup / Prodej Patria Direct
Nastavit SMS / E-Mail alert
Analytický servis
Databanka historických dat
 
  • Poslední aktualizace: 09.05.2026
Popis společnosti
Obecné informace
Název společnostiAsics Corp
Ticker7936
Kmenové akcie:Ordinary Shares
RIC7936.T
ISINJP3118000003
Poslední známé roční výsledky31.12.2025
Poslední známé čtvrtletní výsledky31.12.2025
Počet zaměstnanců k 31.12.2025 9 455
Akcie v oběhu k 31.12.2025 708 635 365
MěnaJPY
Kontaktní informace
UliceLichtstrasse 35
MěstoBASEL
PSČ4056
ZeměSwitzerland
Kontatní osoba 
Funkce kontaktní osoby 
Telefon41 613 241 111
Fax41613247826

Business Summary: ASICS Corporation is a Japan-based company mainly engaged in the manufacture and sale of sports products, such as sports shoes, sportswear, sports equipment and others. The Company operates through six business segments. The Japan Region, Americas Region, Europe Region (including the Middle East and Africa), Oceania/Southeast and South Asia Region, and the East Asia Region segment mainly sell sporting goods. The Others segment is engaged in the manufacture and sale of HAGLOFS brand outdoor products.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Asics Corp revenues increased 20% to Y810.92B. Net income applicable to common stockholders increased 55% to Y98.72B. Revenues reflect European region segment increase of 26% to Y225.81B, Japan Region segment increase of 25% to Y156.39B, China Region segment increase of 20% to Y120.24B, Northern America segment increase from Y18.37B to Y145.48B, Europe segment increase of 24% to Y209.69B.
Odvětvová klasifikace
TRBC2012Pharmaceuticals (NEC)
RBSS2004Pharmaceuticals - Diversified
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSPharmaceutical Preparation Manufacturing
NAICSBiological Product (except Diagnostic) Manufacturing
NAICSMedicinal and Botanical Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
NAICSOphthalmic Goods Manufacturing
NAICSOffices of Other Holding Companies
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)
NAICSDiagnostic Imaging Centers
NAICSIn-Vitro Diagnostic Substance Manufacturing
NAICSDrugs and Druggists' Sundries Merchant Wholesalers
NAICSVeterinary Services
NAICSAll Other Miscellaneous Food Manufacturing
NAICSOther Vegetable (except Potato) and Melon Farming
NAICSOther Nonmetallic Mineral Mining and Quarrying
NAICSGraphic Design Services
NAICSPostharvest Crop Activities (except Cotton Ginning)
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Biological Product (exc Diagnostic) Mfg
NAICS2007Medicinal & Botanical Mfg
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Ophthalmic Goods Mfg
NAICS2007Research and Development in Biotechnology
NAICS2007Offices of Other Holding Companies
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Biological Product (except Diagnostic) Manufacturing
NAICS1997Medicinal and Botanical Manufacturing
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Ophthalmic Goods Manufacturing
NAICS1997Research and Development in the Physical, Engineering, and Life Sciences
NAICS1997Offices of Other Holding Companies
SICPharmaceutical Preparations
SICBiological Prod's Not Diagnostic
SICMedicinals And Botanicals
SICSurgical And Medical Instruments
SICOphthalmic Goods
SICHolding Companies, Nec
SICCommercial Physical Research
SICMedical Laboratories
SICDiagnostic Substances
SICDrugs/proprietaries/sundries
SICVeterinary Services, Specialties
SICFood Preparations, Nec
SICVegetables And Melons
SICMisc Nonmetallic Minerals
SICCommercial Art And Graphic Design
SICCrop Preparation Services
Internetové stránky
Home Page

Investiční disclaimer, Podmínky užívání patria.cz
Zdroj: Reuters, Six Financial Information


  • Poslední aktualizace: 09.05.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, Chief Executive Officer, Representative DirectorYasuhito Hirota6801.01.202429.03.2018
President, Chief Operating Officer, Representative DirectorMitsuyuki Tominaga6401.01.2024
Executive Vice PresidentShinji Senda6401.01.2024
Executive Vice President, Manager of Onitsuka Tiger CompanyRyoji Shoda6201.01.202401.01.2018
Managing Executive Officer, Chief Administrative OfficerTakeshi Horikomi-01.01.202426.03.2021
Executive Officer, Chief Information Officer, CDOHirofumi Oshima-01.01.202601.01.2024
Managing Executive Officer, Chief Director of ChinaKoji Hayashi-01.01.2026
Managing Executive OfficerTomoko Koda-25.03.202201.01.2020
Managing Executive Officer, President and CEO of SubsidiaryKoichiro Kodama-01.01.202101.04.2019
Managing Executive OfficerTsuyoshi Nishiwaki6201.01.2026
Investiční disclaimer, Podmínky užívání patria.cz
Zdroj: Reuters